|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q57769263
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000337.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q57769263
|
|
024
|
|
|
‡a
0000-0001-7245-4552
‡2
orcid
|
|
024
|
|
|
‡a
56835095200
‡2
scopus
|
|
024
|
|
|
‡a
54885075200
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q57769263
|
|
100
|
0 |
|
‡a
Claudia Ribeiro
‡c
researcher ORCID ID = 0000-0001-7245-4552
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Claudia Ribeiro
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Anthropogenic pressure in a Portuguese river: Endocrine-disrupting compounds, trace elements and nutrients
|
|
670
|
|
|
‡a
Author's Assessment of Douro and Ave River (Portugal) lower basin water quality focusing on physicochemical and trace element spatiotemporal changes
|
|
670
|
|
|
‡a
Author's Chiral Drug Analysis in Forensic Chemistry: An Overview.
|
|
670
|
|
|
‡a
Author's Development and optimisation of a GC-MS method for the evaluation of oestrogens and persistent pollutants in river and seawater samples
|
|
670
|
|
|
‡a
Author's Development and validation of a gas chromatography mass spectrometry method for the analysis of phytoestrogens, phytosterols and mycotoxins in estuarine water samples
|
|
670
|
|
|
‡a
Author's Development and Validation of a HPLC‐DAD Method for Determination of Several Endocrine Disrupting Compounds in Estuarine Water
|
|
670
|
|
|
‡a
Author's Dual enantioselective LC-MS/MS method to analyse chiral drugs in surface water: Monitoring in Douro River estuary
|
|
670
|
|
|
‡a
Author's Endocrine disruptors in the Leça River and nearby Porto Coast
|
|
670
|
|
|
‡a
Author's Endocrine disruptors in the Leça River and nearby Porto Coast (NW Portugal): presence of estrogenic compounds and hypoxic conditions
|
|
670
|
|
|
‡a
Author's In vitro exposure of Nile tilapia
|
|
670
|
|
|
‡a
Author's In vitro exposure of Nile tilapia (Oreochromis niloticus) testis to estrogenic endocrine disrupting chemicals: mRNA expression of genes encoding steroidogenic enzymes
|
|
670
|
|
|
‡a
Author's Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review
|
|
670
|
|
|
‡a
Author's Multi-residue method for enantioseparation of psychoactive substances and beta blockers by gas chromatography-mass spectrometry
|
|
670
|
|
|
‡a
Author's New trends in sample preparation techniques for environmental analysis
|
|
670
|
|
|
‡a
Author's Occurrence of persistent organic pollutants in sediments and biota from Portugal versus European incidence: A critical overview.
|
|
670
|
|
|
‡a
Author's Priority Substances and Emerging Organic Pollutants in Portuguese Aquatic Environment: A Review
|
|
670
|
|
|
‡a
Author's Quantification of alprenolol and propranolol in human plasma using a two-dimensional liquid chromatography
|
|
670
|
|
|
‡a
Author's Quantification of alprenolol and propranolol in human plasma using a two-dimensional liquid chromatography (2D-LC).
|
|
670
|
|
|
‡a
Author's Separation of Enantiomers Using Gas Chromatography: Application in Forensic Toxicology, Food and Environmental Analysis
|
|
909
|
|
|
‡a
(scopus) 54885075200
‡9
1
|
|
909
|
|
|
‡a
(scopus) 56835095200
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000172454552
‡9
1
|
|
919
|
|
|
‡a
separationofenantiomersusinggaschromatographyapplicationinforensictoxicologyfoodandenvironmentalanalysis
‡A
Separation of Enantiomers Using Gas Chromatography: Application in Forensic Toxicology, Food and Environmental Analysis
‡9
1
|
|
919
|
|
|
‡a
quantificationofalprenololandpropranololinhumanplasmausinga2dimensionalliquidchromatography
‡A
Quantification of alprenolol and propranolol in human plasma using a two-dimensional liquid chromatography
‡9
1
|
|
919
|
|
|
‡a
prioritysubstancesandemergingorganicpollutantsinportugueseaquaticenvironmentareview
‡A
Priority Substances and Emerging Organic Pollutants in Portuguese Aquatic Environment: A Review
‡9
1
|
|
919
|
|
|
‡a
occurrenceofpersistentorganicpollutantsinsedimentsandbiotafromportugalversuseuropeanincidenceacriticaloverview
‡A
Occurrence of persistent organic pollutants in sediments and biota from Portugal versus European incidence: A critical overview.
‡9
1
|
|
919
|
|
|
‡a
newtrendsinsamplepreparationtechniquesforenvironmentalanalysis
‡A
New trends in sample preparation techniques for environmental analysis
‡9
1
|
|
919
|
|
|
‡a
multiresiduemethodforenantioseparationofpsychoactivesubstancesandbetablockersbygaschromatographymassspectrometry
‡A
Multi-residue method for enantioseparation of psychoactive substances and beta blockers by gas chromatography-mass spectrometry
‡9
1
|
|
919
|
|
|
‡a
liquidchromatographicmethodsforthetherapeuticdrugmonitoringofmethotrexateasclinicaldecisionsupportforpersonalizedmedicineabriefreview
‡A
Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review
‡9
1
|
|
919
|
|
|
‡a
invitroexposureofniletilapiaoreochromisniloticustestistoestrogenicendocrinedisruptingchemicalsmrnaexpressionofgenesencodingsteroidogenicenzymes
‡A
In vitro exposure of Nile tilapia (Oreochromis niloticus) testis to estrogenic endocrine disrupting chemicals: mRNA expression of genes encoding steroidogenic enzymes
‡9
1
|
|
919
|
|
|
‡a
invitroexposureofniletilapia
‡A
In vitro exposure of Nile tilapia
‡9
1
|
|
919
|
|
|
‡a
endocrinedisruptorsinthelecariverandnearbyportocoastnwportugalpresenceofestrogeniccompoundsandhypoxicconditions
‡A
Endocrine disruptors in the Leça River and nearby Porto Coast (NW Portugal): presence of estrogenic compounds and hypoxic conditions
‡9
1
|
|
919
|
|
|
‡a
endocrinedisruptorsinthelecariverandnearbyportocoast
‡A
Endocrine disruptors in the Leça River and nearby Porto Coast
‡9
1
|
|
919
|
|
|
‡a
dualenantioselectivelcmsmsmethodtoanalysechiraldrugsinsurfacewatermonitoringindouroriverestuary
‡A
Dual enantioselective LC-MS/MS method to analyse chiral drugs in surface water: Monitoring in Douro River estuary
‡9
1
|
|
919
|
|
|
‡a
developmentandvalidationofahplcdadmethodfordeterminationofseveralendocrinedisruptingcompoundsinestuarinewater
‡A
Development and Validation of a HPLC‐DAD Method for Determination of Several Endocrine Disrupting Compounds in Estuarine Water
‡9
1
|
|
919
|
|
|
‡a
developmentandvalidationofagaschromatographymassspectrometrymethodfortheanalysisofphytoestrogensphytosterolsandmycotoxinsinestuarinewatersamples
‡A
Development and validation of a gas chromatography mass spectrometry method for the analysis of phytoestrogens, phytosterols and mycotoxins in estuarine water samples
‡9
1
|
|
919
|
|
|
‡a
developmentandoptimisationofagcmsmethodfortheevaluationofoestrogensandpersistentpollutantsinriverandseawatersamples
‡A
Development and optimisation of a GC-MS method for the evaluation of oestrogens and persistent pollutants in river and seawater samples
‡9
1
|
|
919
|
|
|
‡a
chiraldruganalysisinforensicchemistryanoverview
‡A
Chiral Drug Analysis in Forensic Chemistry: An Overview.
‡9
1
|
|
919
|
|
|
‡a
assessmentofdouroandaveriverportugallowerbasinwaterqualityfocusingonphysicochemicalandtraceelementspatiotemporalchanges
‡A
Assessment of Douro and Ave River (Portugal) lower basin water quality focusing on physicochemical and trace element spatiotemporal changes
‡9
1
|
|
919
|
|
|
‡a
anthropogenicpressureinaportugueseriverendocrinedisruptingcompoundstraceelementsandnutrients
‡A
Anthropogenic pressure in a Portuguese river: Endocrine-disrupting compounds, trace elements and nutrients
‡9
1
|
|
919
|
|
|
‡a
quantificationofalprenololandpropranololinhumanplasmausinga2dimensionalliquidchromatography2dlc
‡A
Quantification of alprenolol and propranolol in human plasma using a two-dimensional liquid chromatography (2D-LC).
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
BNF|17069962
|
|
996
|
|
|
‡2
LC|n 85180040
|
|
996
|
|
|
‡2
LC|no2012028564
|
|
996
|
|
|
‡2
LC|n 2015247710
|
|
996
|
|
|
‡2
PTBNP|1478381
|
|
996
|
|
|
‡2
PTBNP|1052142
|
|
996
|
|
|
‡2
NII|DA17167805
|
|
996
|
|
|
‡2
LC|n 2012017381
|
|
996
|
|
|
‡2
ISNI|0000000367208095
|
|
996
|
|
|
‡2
ISNI|0000000070032658
|
|
996
|
|
|
‡2
DNB|1229949828
|
|
996
|
|
|
‡2
LC|no2003096934
|
|
996
|
|
|
‡2
ISNI|0000000052099285
|
|
996
|
|
|
‡2
ISNI|0000000068014434
|
|
996
|
|
|
‡2
PTBNP|719676
|
|
996
|
|
|
‡2
PTBNP|1910078
|
|
996
|
|
|
‡2
PTBNP|936066
|
|
996
|
|
|
‡2
ISNI|0000000069289712
|
|
996
|
|
|
‡2
BLBNB|000425390
|
|
996
|
|
|
‡2
ISNI|0000000428189861
|
|
996
|
|
|
‡2
DNB|1115743031
|
|
996
|
|
|
‡2
ISNI|0000000457228524
|
|
996
|
|
|
‡2
LC|no2004099101
|
|
996
|
|
|
‡2
ISNI|000000007796233X
|
|
996
|
|
|
‡2
ISNI|0000000511642073
|
|
996
|
|
|
‡2
LC|no2019113480
|
|
996
|
|
|
‡2
ISNI|0000000034665175
|
|
996
|
|
|
‡2
BLBNB|000505460
|
|
996
|
|
|
‡2
BLBNB|000294236
|
|
996
|
|
|
‡2
BLBNB|000475960
|
|
996
|
|
|
‡2
PTBNP|1589513
|
|
996
|
|
|
‡2
ISNI|000000008969212X
|
|
996
|
|
|
‡2
PTBNP|1329981
|
|
996
|
|
|
‡2
BLBNB|000242590
|
|
996
|
|
|
‡2
PTBNP|118814
|
|
996
|
|
|
‡2
PTBNP|1435723
|
|
996
|
|
|
‡2
PTBNP|1469967
|
|
996
|
|
|
‡2
ISNI|0000000068476890
|
|
996
|
|
|
‡2
PTBNP|911500
|
|
996
|
|
|
‡2
ISNI|0000000366891355
|
|
996
|
|
|
‡2
LC|n 2018250808
|
|
996
|
|
|
‡2
NTA|330067613
|
|
996
|
|
|
‡2
DNB|1056306793
|
|
996
|
|
|
‡2
SUDOC|183129989
|
|
996
|
|
|
‡2
BLBNB|001456162
|
|
996
|
|
|
‡2
ISNI|0000000495738234
|
|
996
|
|
|
‡2
BLBNB|000383631
|
|
996
|
|
|
‡2
SUDOC|266782299
|
|
996
|
|
|
‡2
ISNI|0000000036687415
|
|
996
|
|
|
‡2
PTBNP|1533220
|
|
996
|
|
|
‡2
PTBNP|1907796
|
|
996
|
|
|
‡2
BLBNB|001479689
|
|
996
|
|
|
‡2
LC|no2002065011
|
|
996
|
|
|
‡2
PTBNP|1417133
|
|
996
|
|
|
‡2
PTBNP|1453561
|
|
996
|
|
|
‡2
BLBNB|000470041
|
|
996
|
|
|
‡2
LC|n 2005178549
|
|
996
|
|
|
‡2
SUDOC|255002173
|
|
996
|
|
|
‡2
BNE|XX4944434
|
|
996
|
|
|
‡2
LC|n 89620056
|
|
996
|
|
|
‡2
LC|n 2021054431
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
